Zargis enters agreement with OTN for testing of telemedicine stethoscope system

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB: SPDE), today announced that it has signed an agreement with the Ontario Telemedicine Network (OTN) providing for the delivery and testing of Zargis' award-winning telemedicine stethoscope system.

OTN is one of the world's largest and most respected telemedicine networks.  An independent, not-for-profit organization funded by the Government of Ontario, Canada, OTN provides access to care for patients in every hospital in Ontario and hundreds of other healthcare locations across the province. In 2010 OTN will conduct more than 100,000 patient visits over more than 2,000 telemedicine systems.

The core component of Zargis' telemedicine stethoscope system, Zargis TeleSteth™, is a component of the Zargis Cardioscan heart sounds analysis software and the Zargis StethAssist® heart and lung sounds visualization software. TeleSteth was developed to extend the practice of auscultation (listening with a stethoscope) to situations and environments where face-to-face encounters are not always convenient or feasible. This platform allows healthcare professionals to share heart, lung and airway sounds with colleagues located across the globe using the Internet or a private network. TeleSteth permits patient sounds to be remotely evaluated in real-time (synchronous) or store-and-forward (asynchronous) mode.

TeleSteth is designed to be accessed from a user's PC via a standard Internet browser. Additionally, for organizations requiring users to access stethoscope sounds from within their private network, TeleSteth can be deployed using Zargis' secure enterprise server platform. All components of Zargis' telemedicine stethoscope system are HIPAA-compliant.

"OTN is one of the world's most sophisticated telemedicine networks and we are pleased to have been selected as the vendor of tele-auscultation solutions for their vast network of healthcare professionals throughout Canada's most populous province," stated Zargis CEO John Kallassy. "Zargis' tele-auscultation platform will help OTN deliver cost-effective, expert healthcare."

"OTN depends on reliable and easy-to-use equipment. Zargis' expertise in the field and the quality of their product met our need for a superior telemedicine stethoscope solution," said Dr. Ed Brown, OTN's CEO.

Source:

Speedus Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U.S. cancer detection severely disrupted during first year of COVID-19, shows incomplete recovery in second year